Fig. 1From: A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTANRelative timing of freedom from most bothersome symptom (MBS) or functional disability and pain status. (a) Sequence of outcomes in patients that experienced MBS freedom and either pain freedom (N = 839) or mild pain (N = 388) at 2 h. (b) Sequence of outcomes in patients that experienced functional disability freedom and either pain freedom (N = 795) or mild pain (N = 116) at 2 h. Notes: Unsustained represented patients who experienced freedom from MBS or functional disability freedom and either freedom from pain or improvement to mild and then moved out of that group prior to 2 h post-dose. The denominator was the total population that achieved the MBS freedom or disability freedom at 2 h post-dose in either the pain free or mild pain groupsBack to article page